NovaBridge Biosciences Investment Income, Interest
NovaBridge Biosciences (NBP) reported Investment Income, Interest of $7.61 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-04-07
- NovaBridge Biosciences investment income, interest for the quarter ending 2020-12-31 was 5.57M CNY, a 28.05% decline year-over-year.
- NovaBridge Biosciences investment income, interest for the quarter ending 2019-12-31 was 7.74M CNY.
CNY
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2023-12-31 | 51.75M CNY 20-F · filed 2024-04-30 | |||
| 2022-12-31 | 26.91M CNY 20-F · filed 2024-04-30 | |||
| 2022-06-30 | 6.57M CNY 6-K · filed 2022-11-10 | |||
| 2021-12-31 | 21.33M CNY 20-F · filed 2024-04-30 | |||
| 2021-06-30 | 9.41M CNY 6-K · filed 2022-11-10 | |||
| 2020-12-31 | 5.57M CNY derived: 20-F 12 month − 6-K 9 month · filed 2023-05-01 | 24.23M CNY 20-F · filed 2023-05-01 | ||
| 2020-09-30 | 18.66M CNY 6-K · filed 2021-02-05 | |||
| 2019-12-31 | 7.74M CNY derived: 20-F 12 month − 6-K 9 month · filed 2022-04-29 | 30.57M CNY 20-F · filed 2022-04-29 | ||
| 2019-09-30 | 22.83M CNY 6-K · filed 2021-02-05 | |||
| 2018-12-31 | 4.60M CNY 20-F · filed 2021-04-28 | |||
| 2017-12-31 | 858.00K CNY 20-F · filed 2020-04-29 |
USD
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month | Investment Income, Interest 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $1.79M derived: 20-F 12 month − 6-K 9 month · filed 2026-04-07 | $3.94M derived: sum of 2 quarters · filed 2026-04-07 | $7.61M 20-F · filed 2026-04-07 | ||
| 2025-09-30 | $2.15M derived: 6-K 9 month − 6-K 6 month · filed 2025-12-18 | $5.82M 6-K · filed 2025-12-18 | |||
| 2025-06-30 | $3.67M 6-K · filed 2025-10-06 | ||||
| 2024-12-31 | $2.20M derived: 20-F 12 month − 6-K 9 month · filed 2026-04-07 | $4.65M derived: sum of 2 quarters · filed 2026-04-07 | $7.49M 20-F · filed 2026-04-07 | ||
| 2024-09-30 | $2.45M derived: 6-K 9 month − 6-K 6 month · filed 2025-12-18 | $5.29M 6-K · filed 2025-12-18 | |||
| 2024-06-30 | $2.84M 6-K · filed 2025-10-06 | ||||
| 2023-12-31 | $9.29M 20-F · filed 2026-04-07 | $7.29M 20-F · filed 2024-04-30 | |||
| 2022-12-31 | $4.95M 20-F · filed 2025-04-03 | $3.90M 20-F · filed 2023-05-01 | |||
| 2022-06-30 | $980.00K 6-K · filed 2022-11-10 | ||||
| 2021-12-31 | $3.35M 20-F · filed 2022-04-29 | ||||
| 2020-12-31 | $965.00K derived: 20-F 12 month − 6-K 9 month · filed 2021-04-28 | $3.71M 20-F · filed 2021-04-28 | |||
| 2020-09-30 | $2.75M 6-K · filed 2021-02-05 | ||||
| 2019-12-31 | $4.39M 20-F · filed 2020-04-29 |